-4.73% intraday APX.AX Appen Limited (ASX) A$1.41 24 Mar 2026: key AI data trends

APX.AX stock trades at A$1.41 intraday on 24 Mar 2026, down 4.73% as sellers react to recent earnings and mixed sector flows. Volume sits near 2,847,304 shares, below the 20-day average, while the 50-day moving average is A$1.49. Investors are watching cash flow and contract wins in AI data services after Appen Limited reported FY metrics on 24 Feb 2026. We use financial ratios, technicals and Meyka AI models to connect the earnings update to today’s price action and highlight scenarios for near-term traders and longer-term holders.

APX.AX stock: Intraday price action and drivers

Appen Limited (APX.AX) is down 4.73% intraday at A$1.41 after opening at A$1.43. The stock is trading between a day low of A$1.37 and a day high of A$1.45, with 2,847,304 shares changing hands. Market participants cite the recent FY results and slower revenue growth as immediate drivers of the pullback. Sector rotation away from high-beta technology names also pressured the price during the Australian session.

APX.AX stock: Financials, margins and valuation

Appen reported trailing twelve‑month revenue of A$348.82M and a net loss of A$32.71M, leaving EPS at -0.12. Key multiples show a negative PE and a price to book ratio near 2.63, reflecting recovery hopes priced into equity. The company holds A$89.69M cash and A$14.10M debt, implying net cash of A$75.59M or A$0.28 per share. These figures explain why investors price APX.AX stock on cash flow and contract cadence rather than earnings today.

APX.AX stock: Growth, cash flow and material risks

Revenue growth is negative year‑on‑year, with fiscal 2024 revenue down roughly 43.04% versus prior periods, while operating cash flow improved to A$34.43M. Free cash flow stands at A$28.39M, giving a FCF yield near 7.54% at the current price. Primary risks include low margins, an Altman Z‑Score of 1.10, and ROE near -20.89%. Those risks are offset by a net cash position and recurring demand for labelled AI data.

APX.AX stock: Technicals, liquidity and Meyka AI grade

Technically, APX.AX shows RSI 43.09 and MACD slightly negative, indicating weak momentum but no strong downtrend. The 50‑day average is A$1.49 and the 200‑day average is A$1.03, so price sits between near‑term resistance and longer‑term support. Average volume is 8.27M and today’s volume is below average, so moves may lack conviction. Meyka AI rates APX.AX with a score out of 100: 63.77 (Grade B, HOLD). This grade factors S&P 500 and sector comparisons, financial growth, key metrics, forecast outputs, and analyst signals. The grade is informational and not financial advice.

APX.AX stock: Outlook, price targets and model forecasts

Meyka AI’s forecast model projects a monthly level near A$1.19 and a 12‑month point estimate of A$0.87, implying downside from today’s A$1.41 if those scenarios play out. As an analyst‑framed view, we set a conservative 12‑month price target of A$1.80, a base case of A$2.20 conditional on contract wins and margin recovery, and a downside scenario target of A$0.80 if growth stalls. Forecasts are model‑based projections and not guarantees. Use contract updates and quarterly guidance to update targets.

APX.AX stock: Investor considerations and sector context

Appen operates in Information Technology Services where demand for labelled AI data remains structural. The technology sector has lagged recent rallies, putting pressure on smaller AI suppliers. Institutional ownership is 21.98% and insiders hold 5.48%, supporting governance continuity. Liquidity is meaningful but uneven, so position sizes should reflect volatility and the company’s recovery timetable.

Final Thoughts

APX.AX stock trades at A$1.41 on 24 Mar 2026 after a -4.73% intraday move tied to earnings and sector flows. The balance sheet shows A$75.59M net cash and positive free cash flow of A$28.39M, but profitability and revenue growth remain the core challenges. Meyka AI’s forecast model projects A$1.19 in the near term and A$0.87 over 12 months, implying an illustrative downside of -38.18% versus today’s price. Our analyst framing places a conservative 12‑month target at A$1.80 and a base case at A$2.20 if Appen accelerates contract wins and margins. Keep monitoring contract disclosures, quarterly guidance and sector momentum. For traders, the technical range between A$1.03 and A$1.90 sets key risk levels. Meyka AI, an AI‑powered market analysis platform, provides these model outputs; forecasts are projections and not guarantees. Follow updates and earnings catalysts closely to reassess risk and reward.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.